Evidence map›Paper›PMID 28423721›Full record

ArticleOncotarget2017

Downregulation of phosphorylated MKK4 is associated with a poor prognosis in colorectal cancer patients.

Pu-Ning Wang, Jun Huang, Ying-Hua Duan, Jia-Min Zhou, Pin-Zhu Huang, Xin-Juan Fan, Yan Huang, Lei Wang, Huan-Liang Liu, Jian-Ping Wang and 1 more

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Expression and Clinical Significance ofInternational journal of molecular sciences · 2025
    Article
  2. Review
  3. Review
  4. Article
  5. MAP Kinases Pathways in Gastric Cancer.International journal of molecular sciences · 2020
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Pu-Ning WangDepartment of Colorectal Surgery, The 6th Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Jun HuangDepartment of Colorectal Surgery, The 6th Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Ying-Hua DuanDepartment of Traditional Chinese Medicine, The 1st Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Jia-Min ZhouDepartment of Colorectal Surgery, The 6th Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Pin-Zhu HuangDepartment of Colorectal Surgery, The 6th Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Xin-Juan FanDepartment of Pathology, The 6th Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Yan HuangDepartment of Pathology, The 6th Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Lei WangDepartment of Colorectal Surgery, The 6th Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Huan-Liang LiuGastrointestinal Diseases Research Institute of Guangdong Province, The 6th Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Jian-Ping WangDepartment of Colorectal Surgery, The 6th Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Mei-Jin HuangDepartment of Colorectal Surgery, The 6th Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitogen-activated protein kinase kinase 4 (MKK4) is a key mediator of Jun N-terminal kinase signaling and influences malignant metastasis. Here, we used immunohistochemistry to assess phosphorylated MMK4 (pMKK4) levels and examine their association with the clinicopathological features of a pilot set of patient samples consisting of normal colonic mucosa (NCM), colorectal adenoma (CA), and colorectal cancer (CRC) tissues. pMKK4 levels were also assessed in a validation set of CRC cases with accompanying follow-up data to confirm their clinicopathological and prognostic significance. pMKK4 levels, which were high in 79.17% of NCM samples, were downregulated in 33.33% of CA and 63.54% of CRC samples. pMKK4 downregulation was associated with metastasis, especially to the liver. In the validation set, pMKK4 downregulation was associated with increases in invasive depth, lymph node metastasis, distant metastasis, and TNM stage. Univariate analysis indicated that pMKK4 score, tumor differentiation, and TNM stage were correlated with disease-free survival and overall survival. Multivariate analysis indicated that decreased pMKK4 expression was an independent risk factor for disease-free survival in CRC patients. These results suggest that CRC patients with low pMKK4 immunochemistry scores should be monitored carefully for early detection of possible recurrences, especially liver metastasis.

Indexed as

Down-RegulationAdultAgedAged, 80 and overColorectal NeoplasmsFemaleHumansMaleMAP Kinase Kinase 4Middle AgedNeoplasm MetastasisNeoplasm StagingPhosphorylationPilot ProjectsPrognosisYoung AdultMAP2K4 protein, humanMAP Kinase Kinase 4colorectal cancermetastasisphosphorylated mitogen-activated protein kinase kinase 4

Identifiers

PMID28423721
PMCPMC5470973
OpenAlexW2593925282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.